HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Beta-endorphin: photoaffinity labelling of a non-opioid binding site in a human neuroblastoma.

Abstract
A photoaffinity reagent 2-nitro-4-azidophenylsulfenyl chloride (2,4-NAPS-Cl) and synthetic analogs of human beta-endorphin (beta h-EP) were employed to demonstrate the presence of receptor sites specific for beta h-EP but of non-opioid character in a human neuroblastoma cell line (IMR-32). The radioactive photoaffinity probe was carried out using [125I-Tyr1,2,4-NAPS-Trp27]-beta h-EP and IMR-32 cell membranes. After solubilization with sodium dodecyl sulfate (SDS) and SDS polyacrylamide gel electrophoresis, a single labelled protein band was identified with a molecular weight of 72,000. Labelling was blocked by beta h-EP or beta h-EP-(6-31) but remained in the presence of beta h-EP-(1-27). The specificity of this band is thus identical to that of the non-opioid site previously characterized. Various nonionic or zwitterionic detergents did not extract the labelled non-opioid site.
AuthorsR G Hammonds Jr, M Westphal, C H Li
JournalBiochemical and biophysical research communications (Biochem Biophys Res Commun) Vol. 128 Issue 3 Pg. 1310-4 (May 16 1985) ISSN: 0006-291X [Print] United States
PMID2988533 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't, Research Support, U.S. Gov't, P.H.S.)
Chemical References
  • Affinity Labels
  • Azides
  • Endorphins
  • Receptors, Opioid
  • beta-Endorphin
  • 2-nitro-4-azidophenylsulfenyl chloride
Topics
  • Affinity Labels
  • Azides
  • Binding Sites
  • Cell Line
  • Endorphins (metabolism)
  • Humans
  • Molecular Weight
  • Neuroblastoma (metabolism)
  • Receptors, Opioid (metabolism)
  • beta-Endorphin

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: